“How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question

BACKGROUND: Most lung cancer patients worldwide [stage IV nonsmall cell lung cancer (NSCLC)] have a poor survival: 25%–30% die <3 months. Yet, of those surviving >3 months, 10%–15% (70,000–105,000 new patients worldwide per year) survive (very) long. Surprisingly, little scientific attention h...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huiru, Li, Hegen, Zhu, Lihua, Feng, Jiali, Huang, Xiange, Baak, Jan P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724440/
https://www.ncbi.nlm.nih.gov/pubmed/34993132
http://dx.doi.org/10.3389/fonc.2021.761042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724440/
https://www.ncbi.nlm.nih.gov/pubmed/34993132
http://dx.doi.org/10.3389/fonc.2021.761042

Ejemplares similares